Intranasal Administration of Neurotoxicants in Animals: Support for the Olfactory Vector Hypothesis of Parkinson’s Disease

The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinson's disease

(2011) Rui D. S. Prediger et al.   CURRENT PHARMACEUTICAL DESIGN

Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease

(2011) Toru Baba et al.   MOVEMENT DISORDERS

PARA-ENCEPHALITIC PARKINSONISM

(2010) CHARLES M. POSER et al.   ACTA NEUROLOGICA SCANDINAVICA

Olfactory function and Parkinson's disease in Southern Brazil

(2010) Ricardo Santin et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease

(2010) N. I. Bohnen et al.   BRAIN

Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson’s disease

(2010) Eduardo L. G. Moreira et al.   JOURNAL OF NEURAL TRANSMISSION

Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease

(2010) Randolph Stephenson et al.   MOVEMENT DISORDERS

Advances in environmental epidemiology

(2010) Caroline M. Tanner   MOVEMENT DISORDERS

Risk is in the Air

(2009) Rui D. S. Prediger et al.   Annals of the New York Academy of Sciences

A highly reproducible rotenone model of Parkinson's disease

(2009) Jason R. Cannon et al.   NEUROBIOLOGY OF DISEASE

From Manganism to Manganese-Induced Parkinsonism: A Conceptual Model Based on the Evolution of Exposure

(2009) Roberto G. Lucchini et al.   NEUROMOLECULAR MEDICINE

Single Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine in C57BL/6 Mice Models Early Preclinical Phase of Parkinson’s Disease

(2009) Rui D. S. Prediger et al.   NEUROTOXICITY RESEARCH

Restoration of Nigrostriatal Dopamine Neurons in Post-MPTP Treatment by the Novel Multifunctional Brain-Permeable Iron Chelator-Monoamine Oxidase Inhibitor Drug, M30

(2009) Shunit Gal et al.   NEUROTOXICITY RESEARCH

Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration

(2009) H. Jang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Environmental toxins and Parkinson's disease: what have we learned from pesticide-induced animal models?

(2009) Francesca Cicchetti et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

The olfactory vector hypothesis of neurodegenerative disease: Is it viable?

(2008) Richard L. Doty   ANNALS OF NEUROLOGY

From nose to brain: understanding transport capacity and transport rate of drugs

(2008) Hongbing Wu et al.   Expert Opinion on Drug Delivery

Maneb potentiates paraquat neurotoxicity by inducing key Bcl-2 family members

(2008) Qingyan Fei et al.   JOURNAL OF NEUROCHEMISTRY

Dietary fats, cholesterol and iron as risk factors for Parkinson's disease

(2008) Karen M. Powers et al.   PARKINSONISM & RELATED DISORDERS

Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease

(2008) J. Salazar et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Neurobiology and treatment of Parkinson's disease

(2008) Anthony H.V. Schapira   TRENDS IN PHARMACOLOGICAL SCIENCES